Literature DB >> 17236118

Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs).

M Roderfeld1, S Hemmann, E Roeb.   

Abstract

Regeneration from liver fibrosis is characterized by four essential events: 1. eradication of pathological agents, 2. apoptosis of activated hepatic stellate cells, 3. remodeling of extracellular matrix, and 4. regeneration of parenchyma and liver function. The temporal and spatial regulation of matrix metalloproteinase (MMP) activity and expression of their specific inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), play a pivotal role in matrix remodeling during hepatic fibrogenesis and recovery. According to current knowledge, the main topics and mechanisms in regeneration from hepatic fibrosis with special emphasis on MMPs and TIMPs are presented. MMP and TIMP expression patterns during hepatic fibrogenesis and fibrolysis, specific characteristics like regulation, expression of cell types, gene expression (RNA/protein), and the underlying disease are summarized. Studies presenting a time course for MMP and TIMP expression during recovery from hepatic fibrosis were taken into consideration to point out a synchronizing behavior in the expression pattern.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236118     DOI: 10.1055/s-2006-927388

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  15 in total

1.  Chunggan extract, a traditional herbal formula, ameliorated alcohol-induced hepatic injury in rat model.

Authors:  Hyeong-Geug Kim; Jung-Min Kim; Jong-Min Han; Jin-Seok Lee; Min-Kyung Choi; Dong-Soo Lee; Yeon-Hwa Park; Chang-Gue Son
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

2.  Effect of Qingguangan on the expressions of MMP-2 and MMP-9 in filtering bleb after trabeculectomy in rabbits.

Authors:  Wen-Juan Li; Qing-Hua Peng; Han-Yu Tan; Yan Liu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

3.  Skeletal muscle-derived stem cells differentiate into hepatocyte-like cells and aid in liver regeneration.

Authors:  Ian H Bellayr; Burhan Gharaibeh; Johnny Huard; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2010-03-25

4.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

5.  Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Steven F Bronk; Sophie Cazanave; Nathan W Werneburg; Justin L Mott; Patricia C Contreras; Gregory J Gores
Journal:  Hepatol Res       Date:  2009-07-13       Impact factor: 4.288

6.  Rat model of fractionated (2 Gy/day) 60 Gy irradiation of the liver: long-term effects.

Authors:  Margret Rave-Fränk; Ihtzaz Ahmed Malik; Hans Christiansen; Naila Naz; Sadaf Sultan; Ahmad Amanzada; Martina Blaschke; Silke Cameron; Shakil Ahmad; Clemens Friedrich Hess; Giuliano Ramadori; Federico Moriconi
Journal:  Radiat Environ Biophys       Date:  2013-04-18       Impact factor: 1.925

7.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

8.  Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production.

Authors:  Hua Wang; Fouad Lafdil; Lei Wang; Shi Yin; Dechun Feng; Bin Gao
Journal:  Cell Biosci       Date:  2011-04-04       Impact factor: 7.133

9.  Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model.

Authors:  J T Stefano; I V A Pereira; M M Torres; P M Bida; A M M Coelho; M P Xerfan; B Cogliati; D F Barbeiro; D F C Mazo; M S Kubrusly; L A C D'Albuquerque; H P Souza; F J Carrilho; C P Oliveira
Journal:  Braz J Med Biol Res       Date:  2015-02-24       Impact factor: 2.590

10.  All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study.

Authors:  Oliver J Kennedy; Jonathan A Fallowfield; Robin Poole; Peter C Hayes; Julie Parkes; Paul J Roderick
Journal:  BMC Public Health       Date:  2021-06-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.